Ownership history in Caption Management, LLC · 5 quarters on record
This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in SPYRE THERAPEUTICS INC (SYRE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 399,900 | +314,700 | +369.4% | 0.09% | $13.1M | $32.76 |
| 2025 Q3 | ADDED | 85,200 | +35,200 | +70.4% | 0.01% | $1.4M | $16.76 |
| 2025 Q3 | REDUCED | 50,000 | -20,000 | -28.6% | 0.01% | $838K | $16.76 |
| 2025 Q2 | ADDED | 70,000 | +30,000 | +75.0% | 0.01% | $1.0M | $14.97 |
As of 2025 Q4 — sorted by position size